EFEllis Franklin

Ellis Franklin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ellis Franklin has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effects of dibutyl phthalate (DBP) on life history traits and population dynamics of Daphnia magna: comparison of two exposure regimes

    by Jérémie Ohanessian, Sophie Martine Prud’HOmme, Ellis Franklin, Géraldine Kitzinger, Catherine Lorgeoux, Elise Billoir, Vincent Felten

    Phthalates are chemical products used as additives in the synthesis of plastics to increase their flexibility and resistance. Among the most frequently detected phthalates in the environment is dibutyl phthalate (DBP). Although ubiquitous in freshwater environments at concentrations in the ng/L to µg/L range, studies on the effects of DBP on Daphnia magna have overlooked the potential effects of exposure at low concentrations (µg/L order) and without solvent. Our work focuses on the chronic effects of DBP on life history traits (survival, growth, reproduction) in the freshwater model species, D. magna (Crustacea). Organisms were exposed to two exposure regimes: from the beginning of embryonic development or from the adult stage, at the third brood, when most of the energy investment in growth is complete. The results obtained show that the DBP exposure regime is an essential parameter in the effects on D. magna life history traits. While no significant response was observed in organisms exposed at the adult stage, disturbances to survival, growth and reproduction were observed at concentrations as low as the µg/L range in organisms exposed at the beginning of embryonic development. The results also demonstrated that exposure to a concentration gradient of DBP results in different dose-dependent response typologies, depending on the life history traits measured. For survival, the dose-response relationship was non-monotonic, with greater juvenile mortality at intermediate concentrations (100, 280 and 500 µg/L) than at higher concentrations (1000 and 2000 µg/L). For effects on growth and reproduction, the responses followed classic monotonic dose-response relationships with low sensitivities. At the end of the experiment, the EC10-25d values were 1.01 µg/L for reproduction and 79.22 µg/L for growth. However, when calculated at earlier timepoints, the EC10-4d and the EC10-7d for growth were 0.25 µg/L and 1.16 µg/L. Furthermore, projecting these results to the population level suggests that exposure to DBP from early embryonic development leads to a decrease in growth rate and a change in population structure.


  • Open Access

    Cluefish: mining the dark matter of transcriptional data series with over-representation analysis enhanced by aggregated biological prior knowledge

    by Ellis Franklin, Elise Billoir, Philippe Veber, Jérémie Ohanessian, Marie Laure Delignette-Muller, Sophie Martine Prud’hOmme

    Interpreting transcriptomic data presents significant challenges, particularly in non-targeted approaches. While modern functional enrichment methods are well-suited for experimental designs involving two conditions, they are less applicable to data series. In this context, we developed Cluefish, a free and open-source, semi-automated R workflow designed for untargeted, comprehensive biological interpretation of transcriptomic data series. Cluefish applies over-representation analysis on pre-clustered protein–protein interaction networks, using clusters as anchors to identify smaller, more specific biological functions. Innovative features, including cluster merging and recovery of isolated genes through shared biological contexts, enable a more complete exploration of the data. We applied Cluefish to an in-house dataset with zebrafish exposed to a dose-gradient of dibutyl phthalate and to two published toxicology datasets featuring different organisms. Combined with DRomics, a tool for dose–response analysis—Cluefish identified gene clusters deregulated at low doses and linked to biological functions overlooked by the standard approach. Notably, it revealed that retinoid signaling disruption may be the most sensitive pathway affected by dibutyl phthalate during zebrafish development, potentially leading to morphological changes. The Cluefish workflow aims to provide valuable clues for biological hypothesis generation and experimental validation. It is freely available at https://github.com/ellfran-7/cluefish.

  • Open Access

    Effects of dibutyl phthalate (DBP) on life history traits and population dynamics of Daphnia magna : comparison of two exposure regimes

    by Jérémie Ohanessian, Sophie Martine Prud’HOmme, Ellis Franklin, Géraldine Kitzinger, Catherine Lorgeoux, Elise Billoir, Vincent Felten

    : Phthalates are chemical products used as additives in the synthesis of plastics to increase their flexibility and resistance. Among the most frequently detected phthalates in the environment is dibutyl phthalate (DBP). Although ubiquitous in freshwater environments at concentrations in the ng/L to µg/L range, studies on the effects of DBP on Daphnia magna have overlooked the potential effects of exposure at low concentrations (µg/L order) and without solvent. Our work focuses on the chronic effects of DBP on life history traits (survival, growth, reproduction) in the freshwater model species, D. magna (Crustacea). Organisms were exposed to two exposure regimes: from the beginning of embryonic development or from the adult stage, at the third brood, when most of the energy investment in growth is complete. The results obtained show that the DBP exposure regime is an essential parameter in the effects on D. magna life history traits. While no significant response was observed in organisms exposed at the adult stage, disturbances to survival, growth and reproduction were observed at concentrations as low as the µg/L range in organisms exposed at the beginning of embryonic development. The results also demonstrated that exposure to a concentration gradient of DBP results in different dose-dependent response typologies, depending on the life history traits measured. For survival, the dose-response relationship was non-monotonic, with greater juvenile mortality at intermediate concentrations (100, 280 and 500 µg/L) than at higher concentrations (1000 and 2000 µg/L). For effects on growth and reproduction, the responses followed classic monotonic dose-response relationships with low sensitivities. At the end of the experiment, the EC10-25d values were 1.01 µg/L for reproduction and 79.22 µg/L for growth. However, when calculated at earlier timepoints, the EC10-4d and the EC10-7d for growth were 0.25 µg/L and 1.16 µg/L. Furthermore, projecting these results to the population level suggests that exposure to DBP from early embryonic development leads to a decrease in growth rate and a change in population structure.


  • Open Access

    Cluefish: mining the dark matter of transcriptional data series with over-representation analysis enhanced by aggregated biological prior knowledge

    by Ellis Franklin, Elise Billoir, Philippe Veber, Jérémie Ohanessian, Marie Laure Delignette-Muller, Sophie Martine Prud’homme

    Interpreting transcriptomic data presents significant challenges, particularly in non-targeted approaches. While modern functional enrichment methods are well-suited for experimental designs involving two conditions, they are less applicable to data series. In this context, we developed Cluefish, a free and open-source, semi-automated R workflow designed for untargeted, comprehensive biological interpretation of transcriptomic data series. Cluefish applies over-representation analysis on pre-clustered protein-protein interaction networks, using clusters as anchors to identify smaller, more specific biological functions. Innovative features, including cluster merging and recovery of isolated genes through shared biological contexts, enable a more complete exploration of the data. We applied Cluefish to an in-house dataset with zebrafish exposed to a dose-gradient of dibutyl phthalate, and to two published toxicology datasets featuring different organisms. Combined with DRomics, a tool for dose-response analysis—Cluefish identified gene clusters deregulated at low doses and linked to biological functions overlooked by the standard approach. Notably, it revealed that retinoid signalling disruption may be the most sensitive pathway affected by dibutyl phthalate during zebrafish development, potentially leading to morphological changes. The Cluefish workflow aims to provide valuable clues for biological hypothesis generation and experimental validation. It is freely available at https://github.com/ellfran-7/cluefish . GRAPHICAL

  • Open Access

    Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease

    by Antoine Leuzy, Alexa Pichet Binette, Jacob W. Vogel, Gregory Klein, Edilio Borroni, Matteo Tonietto, Olof Strandberg, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Michael J. Pontecorvo, et al.

    Importance: Longitudinal tau positron emission tomography (PET) is a relevant outcome in clinical trials evaluating disease-modifying therapies in Alzheimer disease (AD). A key unanswered question is whether the use of participant-specific (individualized) regions of interest (ROIs) is superior to conventional approaches where the same ROI (group-level) is used for each participant.Objective: To compare group- and participant-level ROIs in participants at different stages of the AD clinical continuum in terms of annual percentage change in tau-PET standardized uptake value ratio (SUVR) and sample size requirements.Design, Setting, and Participants: This was a longitudinal cohort study with consecutive participant enrollment between September 18, 2017, and November 15, 2021. Included in the analysis were participants with mild cognitive impairment and AD dementia from the prospective and longitudinal Swedish Biomarkers For Identifying Neurodegenerative Disorders Early and Reliably 2 (BioFINDER-2) study; in addition, a validation sample (the AVID 05e, Expedition-3, Alzheimer’s Disease Neuroimaging Initiative [ADNI], and BioFINDER-1 study cohorts) was also included.Exposures: Tau PET (BioFINDER-2, [18F]RO948; validation sample, [18F]flortaucipir), 7 group-level (5 data-driven stages, meta-temporal, whole brain), and 5 individualized ROIs.Main Outcomes and Measures: Annual percentage change in tau-PET SUVR across ROIs. Sample size requirements in simulated clinical trials using tau PET as an outcome were also calculated.Results: A total of 215 participants (mean [SD] age, 71.4 (7.5) years; 111 male [51.6%]) from the BioFINDER-2 study were included in this analysis: 97 amyloid-β (Aβ)–positive cognitively unimpaired (CU) individuals, 77 with Aβ-positive mild cognitive impairment (MCI), and 41 with AD dementia. In the validation sample were 137 Aβ-positive CU participants, 144 with Aβ-positive MCI, and 125 with AD dementia. Mean (SD) follow-up time was 1.8 (0.3) years. Using group-level ROIs, the largest annual percentage increase in tau-PET SUVR in Aβ-positive CU individuals was seen in a composite ROI combining the entorhinal cortex, hippocampus, and amygdala (4.29%; 95% CI, 3.42%-5.16%). In individuals with Aβ-positive MCI, the greatest change was seen in the temporal cortical regions (5.82%; 95% CI, 4.67%-6.97%), whereas in those with AD dementia, the greatest change was seen in the parietal regions (5.22%; 95% CI, 3.95%-6.49%). Significantly higher estimates of annual percentage change were found using several of the participant-specific ROIs. Importantly, the simplest participant-specific approach, where change in tau PET was calculated in an ROI that best matched the participant’s data-driven disease stage, performed best in all 3 subgroups. For the power analysis, sample size reductions for the participant-specific ROIs ranged from 15.94% (95% CI, 8.14%-23.74%) to 72.10% (95% CI, 67.10%-77.20%) compared with the best-performing group-level ROIs. Findings were replicated using [18F]flortaucipir.Conclusions and Relevance: Finding suggest that certain individualized ROIs carry an advantage over group-level ROIs for assessing longitudinal tau changes and increase the power to detect treatment effects in AD clinical trials using longitudinal tau PET as an outcome.


  • P1‐497: CLINICAL CORRELATES OF LEWY BODY PATHOLOGY IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE

    by Jonathan Vöglein, Katrina L. Paumier, Nigel J. Cairns, Erin E. Franklin, Richard J. Perrin, Chengjie Xiong, Mathias Jucker, Randall J. Bateman, Adrian Danek, John C. Morris, et al.